Search results
Mirikizumab Shows Promise for Moderate to Severe Crohn's
Medscape· 21 hours agoAlready approved for ulcerative colitis, the monoclonal antibody mirikizumab met study endpoints for...
Duoning Collaborates with Bioelectronica to Commercialize a Single-Cell Sorting System for Antibody...
FOX 23 News Albany· 14 hours agoDuoning Biotechnology Group ("Duoning"), a leading one-stop bioprocess provider in China, today...
Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis -...
Benzinga· 6 days agoCelldex Therapeutics, Inc. CLDX today announced that the first patient has been dosed in the Company's Phase 2 subcutaneous study of barzolvolimab in prurigo nodularis (PN). Barzolvolimab is ...
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace· 9 hours agoFundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 7 days agoSanofi plans to invest €1bn in Vitry-sur-Seine to construct a new unit in a bid to double the ...
Abzena at BIO 2024: Showcasing innovation in cell line development technology
BioPharma-Reporter· 6 days agoAbzena has recently launched our AbZelect and AbZelectPRO cell line development (CLD) platforms, to...
Adagene Inc. (NASDAQ:ADAG) Short Interest Up 6.3% in April
ETF DAILY NEWS· 4 days agoAdagene Inc. (NASDAQ:ADAG – Get Free Report) saw a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 15,100 shares, an increase ...
Canada's vaccine advisers recommend RSV shots for infants
CBC via Yahoo News· 3 days agoCanada's vaccine advisory group said Friday it recommends building toward immunizing all infants...
Bank of America Predicts up to ~200% Surge for These 2 ‘Strong Buy’ Stocks
TipRanks via Yahoo Finance· 2 days agoNew indicators of a cooling economy eased inflation concerns, driving the S&P 500 to record highs...
Blackstone-backed biotech launches with up to $300M for immune drug
BioPharma Dive via Yahoo Finance· 6 days agoThe drug, solrikitug, originally came from Merck and has the potential to treat a variety of immune...